Trade Mark Journal No.2026/041 9 October 2026

WO0000001938825 (1)

Office of origin: United States of America

Date of International Registration:18 August 2026
Date of designation in the UK: 18 August 2026
Image for mark 1938825 PrimeLine

International priority date claimed: 18 August 2026 (United States of America) (50057318)
Class 1
Genetically modified cells for research use only in drug discovery, toxicology, and other pharmaceutical applications.

Lonza Walkersville, Inc.

Representative: Lawrence J. Crain Greer, Burns & Crain, Ltd., 200 West Madison Street,, Suite 2100, Chicago IL 60606, UNITED STATES OF AMERICA